Protocol to generate microglia-containing cerebral organoids to model HIV neuroinflammation
- STAR Protoc. 2026 Jun 19;7(2):104604. doi: 10.1016/j.xpro.2026.104604.
- 1. Department of Microbial Pathogens and Immunity, Rush University Medical Center, Chicago, IL 60612, USA.
- 2. Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London SE1 9RT, England.
- 3. Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London SE1 9RT, England; Centre for Gene Therapy & Regenerative Medicine, School of Basic & Medical Biosciences, King's College London, London SE1 9RT, England.
- 4. Department of Microbial Pathogens and Immunity, Rush University Medical Center, Chicago, IL 60612, USA. Electronic address: [email protected].
- 5. Department of Microbial Pathogens and Immunity, Rush University Medical Center, Chicago, IL 60612, USA. Electronic address: [email protected].
Cerebral organoids (COs) are valuable for studying neurodegenerative diseases and pathogens, but their limited microglia pose challenges. Here, we present a protocol to generate organoids with physiologically relevant microglia (CO-iMs). We describe steps for differentiating induced pluripotent stem cells (iPSCs) into mesoderm, seeding embryoid bodies (EBs), and harvesting hematopoietic progenitor cells (HPCs). We detail procedures for co-culturing HPCs and iPSCs to generate CO-iMs, followed by their Infection and treatment. The model provides a platform to study viral infections and neuroinflammation. For complete details on the use and execution of this protocol, please refer to Narasipura et al.1.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
Research Areas: Infection